ERBB2 and breast cancer: Analyzing the expression of estrogen receptor (ER), progesterone receptor (PR), and epidermal growth factor receptor 2 (ERBB2, NEU or HER2) is still the basis for breast cancer stratification and an important determinant of breast carcinoma cell phenotype.